Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R sdAb Bispecific Antibody (IgG-sdAb)
Recombinant Anti-CD3 x Anti-IGF1R sdAb Bispecific Antibody (IgG-sdAb) (CAT#: IGVHH-029)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-sdAb) is designed to be expressed as a LC and an extended HC with a sdAb linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy. As required, the sdAb can also be fused to the C terminus of the LC.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R sdAb Bispecific Antibody (IgG-sdAb) (IGVHH-029). Click the button below to contact us or submit your feedback about this product.